Indications:
Menveo is indicated for active immunization of children (from 2 months of age), adolescents and adults at risk of exposure to Neisseria meningitidis groups A, C, W-135 and Y, to prevent invasive disease.
The use of this vaccine should be in accordance with official recommendations.
|